Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03972488
Title Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET (NETTER-2)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Advanced Accelerator Applications
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Yale Cancer Center New Haven Connecticut 06520 United States Details
USF - H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
University of Iowa Hospitals and Clinics - Oncology Iowa City Iowa 52242 United States Details
University of Kentucky UK Markey Cancer Center Lexington Kentucky 40536 United States Details
Mayo Clinic - Oncology Rochester Minnesota 55905 United States Details
Nebraska Cancer Centers Omaha Nebraska 68130 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
London Health Sciences Centre, University of Western Ontario - Oncology London Canada Details
Centre Hospitalier Universitaire de Quebec Quebec Canada Details
Sunnybrook Health Sciences Centre Toronto Canada Details
BC Cancer Agency Vancouver Canada Details
CHU Paris Nord-Val de Seine Clichy France Details
Hospices Civils de Lyon (HCL) - Hopital Edouard Herriot Lyon France Details
Institut du Cancer de Montpellier - Oncology Montpellier France Details
CHU-Hôtel Dieu Service de Médecine Nucléaire Nantes France Details
Institut Gustave Roussy Villejuif France Details
Universitätsklinikum Erlangen Erlangen Germany Details
Universitätsklinikum Essen - Klinik für Nuklearmedizin Essen Germany Details
A.O.di Bologna Policl.S.Orsola Bologna Italy Details
University of Genova - Oncology Genova Italy Details
Istituto Oncologico Romagnolo Meldola Italy Details
Fondazione Irccs Istituto Nazionale Tumori Milano Italy Details
Ieo, Irccs Milano Italy Details
IRCCS fondazione Pascale - Oncology Napoli Italy Details
Arcispedale Santa Maria Nuova, Reggio Emilia - Oncology Reggio Emilia Italy Details
Azienda Ospedaliera Sant'Andrea - Università La Sapienza U.O.C. Mal App. Digerente e - Oncology Roma Italy Details
Seoul National University Bundang Hospital Seongnam-Si Korea, Republic of Details
Asan Medical Center - Oncology Seoul Korea, Republic of Details
Seoul National University Hospital - Department of Internal Medicine Seoul Korea, Republic of Details
Severance Hospital, Yonsei University Health System - Medical Oncology Seoul Korea, Republic of Details
Erasmus Medisch Centrum Rotterdam Netherlands Details
UMC Utrecht - Oncology Utrecht Netherlands Details
Hospital Universitario Vall d'Hebrón Barcelona Spain Details
Hospital General Universitario Gregorio Marañón Madrid Spain Details
Hospital Universitario Ramón y Cajal Madrid Spain Details
Complejo Hospitalario Universitario Santiago de Compostela Santiago de Compostela Spain Details
Hospital Universitari i Politecnic La Fe Valencia Spain Details
Bristol Haematology and Oncology Centre Bristol United Kingdom Details
Guys And St Thomas Hospital London United Kingdom Details
Kings College Hospital - Oncology London United Kingdom Details
Royal Free Hospital, London London United Kingdom Details
Weston Park Hospital Sheffield United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field